BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF
34.00
+0.20 (0.59%)
At close: Jul 31, 2025, 5:20 PM CET
Exscientia Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 |
---|
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
---|
| 1.21 | 1.14 |
| 1.21 | 1.14 |
| 6.50% | - |
| 1.21 | 1.14 |
| 7 | 4.02 |
| 12.95 | 14.83 |
| 19.94 | 18.84 |
| -18.73 | -17.7 |
| -1.03 | -0.7 |
Interest & Investment Income | 0.5 | 0.48 |
Currency Exchange Gain (Loss) | 0.13 | -0.16 |
Other Non Operating Income (Expenses) | 0.42 | -0.22 |
| -18.72 | -18.3 |
| -18.72 | -18.3 |
| -18.72 | -18.3 |
Shares Outstanding (Basic) | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 |
| 11.60% | - |
| -5.62 | -6.13 |
| -5.62 | -6.13 |
| -15.61 | -11.7 |
| -4.68 | -3.92 |
| 100.00% | 100.00% |
| -1544.11% | -1554.17% |
| -1543.20% | -1606.76% |
| -1287.06% | -1027.57% |
| -18.67 | -17.65 |
| 0.06 | 0.06 |
| -18.73 | -17.7 |
| 1.21 | 1.14 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.